Treatment Outcomes in PASC Patients With Neurocognitive Impairment

Completed

Conditions studied: Long COVID

In brief

Longitudinal study collecting retrospective and prospective data on treatments received and change in quality of life among patients with neurocognitive symptoms attending a Long COVID clinic

Key facts

Study ID

NCT07090564

Run by

Ohio State University

People needed

171

Starts

2022-10-12

Expected to finish

2024-04-01

Last updated by the study team

2026-03-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Long COVID assigned by a PCRC provider and at least one of a prespecified set of ICD10 codes used by clinic providers to indicate neurologic symptoms. Since no diagnostic biomarkers or established criteria existed during the period of the study, Long COVID diagnosis was based on clinical judgement, taking into account the timing of symptom onset relative to acute COVID19 and the presence or absence of alternate diagnoses that might explain them.

You may not qualify if…

• Age under 18
• Failure to complete pre-visit PROMIS29 questionnaire
• Absence of a Long COVID diagnosis or concurrent neurologic diagnosis.

Where it is running

• The Ohio State University Wexner Medical Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.